NCT06396754View on ClinicalTrials.gov

Deployment and Clinical Evaluation of an AI-powered Digital Oncology Biomarker Tool to guidE Treatment in TNBC

Not yet recruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Triple Negative Breast Cancer
Interventions
OTHER

AI-analysis on diagnostic and surgical specimens

The analysis will report a list of AI-based biomarkers to assess the tumour-immune spatial microenvironment as well as final spatial immune-ecology prognostic (SIPA) reports for every patient.

All Listed Sponsors
collaborator

Case45 Ltd

UNKNOWN

lead

Institute of Cancer Research, United Kingdom

OTHER

NCT06396754 - Deployment and Clinical Evaluation of an AI-powered Digital Oncology Biomarker Tool to guidE Treatment in TNBC | Biotech Hunter | Biotech Hunter